Alvotech (ALVO) Assets (2020 - 2026)
Alvotech's (ALVO) quarterly Assets came in at $1.6 billion in Q2 2026, up 13.98% on a YoY basis from $1.4 billion in Q2 2025, and up 11.7% quarter-over-quarter from $1.4 billion in Q1 2026.
Analysis
Alvotech (ALVO) Assets (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Assets for 7 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets rose 13.98% year-over-year to $1.6 billion; the trailing twelve-month figure through Jun 2026 stood at $1.6 billion (up 13.98% YoY), and the FY2025 full-year result was $1.5 billion, up 21.75% from the prior year.
- Assets improved to $1.6 billion in Q2 2026 per ALVO's latest filing, from $1.4 billion in the prior quarter.
- Across five years, Assets topped out at $1.6 billion in Q2 2026 and bottomed at $774.5 million in Q2 2022.
- Historically, Assets has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2024.
- The sharpest annual moves came in 2022 and 2026: Assets surged 38.54% in 2022, then grew 13.98% in 2026.
- Over 5 years, Assets stood at $828.4 million in 2022, then grew by 14.68% to $950.1 million in 2023, then gained by 28.56% to $1.2 billion in 2024, then gained by 21.75% to $1.5 billion in 2025, then increased by 6.75% to $1.6 billion in 2026.
- According to Business Quant data, Assets over the past three periods registered $1.6 billion, $1.4 billion, and $1.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 39.86 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 35.04 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 6.08 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 3.78 Bn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 24.79 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 1.59 Bn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 1.49 Bn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 1.74 Bn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 75.75 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | 25.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 Bn |
| Mar 31, 2026 | 1.42 Bn |
| Dec 31, 2025 | 1.49 Bn |
| Sep 30, 2025 | 1.41 Bn |
| Jun 30, 2025 | 1.39 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.22 Bn |
| Sep 30, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.07 Bn |
| Mar 31, 2024 | 1.06 Bn |
| Dec 31, 2023 | 950.09 Mn |
| Jun 30, 2023 | 910.66 Mn |
| Dec 31, 2022 | 828.44 Mn |
| Jun 30, 2022 | 774.50 Mn |
| Dec 31, 2021 | 597.98 Mn |
| Dec 31, 2020 | 474.42 Mn |